REFERENCEGoogle News, India stocks·8d★ ON YOUR LIST
Stocks to Watch Today: Aurobindo Pharma, Highway Infra, NCC, Blue Dart, Symbiotec Pharma, Shadowfax,... - Moneycontrol.comStock · NSE
AUROPHARMA
1,676.80▲ 0.00 (0.00%)Last 2 days · 15m candles9/10/2026, 02:53:35
Open: 1,684.70High: 1,694.70Low: 1,659.70Prev: 1,676.80
Positive
10
Neutral
19
Negative
1
News mentioning AUROPHARMA
Sentiment: +30%← All news
VERIFIEDET Markets·9d★ ON YOUR LIST
Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speciality drugsAI summary· POSITIVE
- ·India and 19 other countries are exempted from 100% tariffs on certain patented specialty pharmaceuticals and ingredients by the US.
- ·Sun Pharma and Aurobindo Pharma are among the Indian pharma stocks in focus due to this exemption.
- ·Eligible products include rare-disease drugs, gene and cell therapies, and infertility treatments, while generic medicines are unaffected.
VERIFIEDET Stocks·14d★ ON YOUR LIST
Allied Blenders among 7 stocks that hit 52-week highs and rallied up to 17% in a monthAI summary· NEUTRAL
- ·Seven BSE 500 stocks reached new 52-week highs on Thursday.
- ·Allied Blenders was among the stocks that hit 52-week highs.
- ·These stocks experienced monthly gains of up to 17%.
VERIFIEDET Stocks·22d★ ON YOUR LIST
JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?AI summary· POSITIVE
- ·JM Financial maintained Buy ratings on Dr Reddy’s Laboratories and Aurobindo Pharma.
- ·The brokerage anticipates up to 28% upside for both companies in the next 12 months.
- ·JM Financial cited stronger earnings growth, business diversification, and new product launches as key drivers.
VERIFIEDMint Markets·23d★ ON YOUR LIST
Top stocks in focus tomorrow: Investors must watch NBCC, BHEL, Bharat Forge shares on Wed, 16 Sept | TriggersAI summary· NEUTRAL
- ·Investors will monitor Tata Communications and Aurobindo Pharma on September 16.
- ·Business updates for these companies include new product launches.
- ·Other updates involve joint ventures and settlement agreements.
VERIFIEDMint Markets·38d★ ON YOUR LIST
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 1 September 2026AI summary· NEUTRAL
VERIFIEDET Finance·38d★ ON YOUR LIST
Aurobindo Pharma launches generic Advair Diskus for asthma and COPD in USAI summary· NEUTRAL
- ·Lannett Company, a subsidiary of Aurobindo Pharma, has launched a generic version of Advair Diskus in the US.
- ·This marks Aurobindo Pharma's first complex inhalation product to be marketed in the US, a market valued at approximately $908 million.
- ·Cipla's US division has also received FDA approval for the same generic product.
VERIFIEDET Stocks·38d★ ON YOUR LIST
Aurobindo Pharma among 5 stocks hitting 52-week highs; surge up to 18% in a monthAI summary· NEUTRAL
- ·Five BSE 200 stocks, including Aurobindo Pharma, reached new 52-week highs.
- ·Other stocks hitting 52-week highs were Lenskart, Coforge, Oracle Financial Services Software, and Bajaj Auto.
- ·This occurred despite a generally weak market sentiment.
VERIFIEDET Markets·38d★ ON YOUR LIST
Aurobindo Pharma among 5 stocks hitting 52-week highs; surge up to 18% in a monthAI summary· NEUTRAL
- ·Five BSE 200 stocks, including Aurobindo Pharma, reached new 52-week highs.
- ·Other stocks hitting highs were Lenskart, Coforge, Oracle Financial Services Software, and Bajaj Auto.
- ·This occurred despite a generally weak market sentiment.
VERIFIEDET Stocks·38d★ ON YOUR LIST
Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTDAI summary· POSITIVE
- ·Aurobindo Pharma's shares increased following its subsidiary Lannett Company's launch of generic Advair Diskus in the US.
- ·The generic Advair Diskus is available in two strengths and is the first commercialized product from Aurobindo's inhalation pipeline.
- ·Aurobindo Pharma's stock has seen a year-to-date gain of 41.16% in 2026.
VERIFIEDET Markets·38d★ ON YOUR LIST
Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTDAI summary· POSITIVE
- ·Aurobindo Pharma's subsidiary Lannett Company launched a generic Advair Diskus in the US.
- ·The product is available in two strengths and is the first commercialised product from Aurobindo's inhalation pipeline.
- ·Aurobindo Pharma's stock has risen 41.16% year-to-date.
REFERENCEGoogle News, India stocks·39d★ ON YOUR LIST
Stocks to Watch Today: HDFC Bank, Avantel, Cipla, Max Estates, Clean Max, Axiscades, Aurobindo Pharma,... - Moneycontrol.comVERIFIEDMint Markets·40d★ ON YOUR LIST
Stocks to watch on August 31: M&M, Cupid, Aurobindo Pharma, OLA, KP Green Engineering among shares in focusAI summary· NEUTRAL
- ·Mahindra & Mahindra and Cupid are among the stocks investors will focus on August 31.
- ·Aurobindo Pharma and OLA are also highlighted as companies in focus.
- ·Indian indices faced a three-week losing streak despite a positive close on August 28.
VERIFIEDET Finance·45d★ ON YOUR LIST
USFDA ends inspection of Aurobindo Pharma arm's facility with 4 observationsAI summary· NEUTRAL
- ·Aurobindo Pharma's subsidiary Lannett Company LLC's facility was inspected by the USFDA.
- ·The inspection took place from August 17-21, 2026, at the Seymour, USA facility.
- ·Four procedural observations were noted during the inspection.
VERIFIEDMint Markets·45d★ ON YOUR LIST
Aurobindo Pharma US subsidiary Lannett Company LLC faces 4 observations from the USFDAAI summary· NEUTRAL
- ·Aurobindo Pharma's US subsidiary, Lannett Company LLC, was inspected by the USFDA from August 17-21, 2026.
- ·The inspection was routine.
- ·The USFDA issued four observations at the conclusion of the inspection.
VERIFIEDET Finance·52d★ ON YOUR LIST
Aurobindo Pharma’s Raleigh plant gets 'Voluntary Action Indicated' classification from US FDAAI summary· NEUTRAL
- ·Aurobindo Pharma's US facility in Raleigh received a Voluntary Action Indicated classification from the US FDA.
- ·The US FDA has closed its inspection of the Raleigh manufacturing plant.
- ·The VAI classification permits the progression of applications for inhalers and other products manufactured at the facility.
VERIFIEDET Finance·55d★ ON YOUR LIST
Aurobindo Pharma arm Eugia Pharma's Telangana unit gets warning letter from USFDAAI summary· NEUTRAL
- ·Aurobindo Pharma's subsidiary Eugia Pharma received a warning letter from the USFDA.
- ·The letter follows an inspection of their Telangana formulation manufacturing facility which had four observations.
- ·Existing US market supplies are unaffected by this development.
VERIFIEDET Markets·56d★ ON YOUR LIST
Lenskart Solutions among 7 stocks hitting 52-week highs; surge up to 20% in a monthAI summary· POSITIVE
- ·Seven BSE 200 stocks reached new 52-week highs on a day the Sensex increased by 113 points.
- ·Paytm saw the largest monthly increase at 19%.
- ·Other stocks reaching 52-week highs included Bosch, Lenskart Solutions, Aurobindo Pharma, Pidilite, Solar Industries India, and Zydus Lifesciences.
VERIFIEDET Stocks·62d★ ON YOUR LIST
Aurobindo Pharma among 8 stocks hitting 52-week highs; surge up to 20% in a monthAI summary· POSITIVE
- ·Eight stocks from the BSE 200 index reached new 52-week highs.
- ·Aurobindo Pharma was among the stocks hitting a 52-week high.
- ·These stocks have seen surges of up to 20% in the past month.
REFERENCEGoogle News, India stocks·64d★ ON YOUR LIST
Stocks to Watch Today: Aurobindo Pharma, Cohance, Hindalco, Cummins, PB Fintech, Navin Fluorine, Biocon,... - Moneycontrol.comVERIFIEDMint Markets·78d★ ON YOUR LIST
Lupin, Sun Pharma to Cipla: Pharma stocks decline after Trump’s tariffs plan on generic medicines importAI summary· NEGATIVE
- ·Several Indian pharmaceutical companies experienced a decline in their stock prices.
- ·Aurobindo Pharma, Ajanta Pharma, Lupin, Gland Pharma, and Zydus Lifesciences were among the top decliners.
- ·The decline occurred following a plan by Donald Trump regarding tariffs on generic medicine imports.
REFERENCEGoogle News, India stocks·79d★ ON YOUR LIST
Stocks to Watch Today: Maruti Suzuki, Aurobindo Pharma, Gabriel India, Cyient DLM, Mastek, Indian Hotels,... - Moneycontrol.comVERIFIEDEconomic Times News·94d★ ON YOUR LIST
LKP Securities’ top 3 picks: High-conviction breakout stocks targeting strong gainsAI summary· POSITIVE
- ·LKP Securities has identified Aegis Vopak, Lodha, and Aurobindo Pharma as short-term stock picks.
- ·The selections are based on strong technical indicators such as chart breakouts and bullish RSI crossovers.
- ·Positive market sentiment is currently supporting selective stock opportunities.
VERIFIEDEconomic Times News·96d★ ON YOUR LIST
F&O Talk: Smallcap index better placed than Nifty, says Sudeep Shah; picks 9 stocks for next weekAI summary· NEUTRAL
- ·SBI Securities anticipates Nifty's breakout strengthening if it surpasses 24,450, potentially reaching 24,900.
- ·Small-cap stocks continue to exhibit outperformance.
- ·Aurobindo Pharma, DLF, Titan, and Oberoi Realty are among the highlighted stock picks.
VERIFIEDET Markets·96d★ ON YOUR LIST
F&O Talk: Smallcap index better placed than Nifty, says Sudeep Shah; picks 9 stocks for next weekAI summary· POSITIVE
- ·SBI Securities anticipates Nifty's breakout to strengthen if it crosses 24,450, potentially reaching 24,900.
- ·Small-cap stocks continue to show outperformance, and Bank Nifty maintains a positive outlook.
- ·Aurobindo Pharma, DLF, Titan, and Oberoi Realty are highlighted as top stock picks.
VERIFIEDMint Markets·99d★ ON YOUR LIST
Aurobindo Pharma’s investors await next leg of growthAI summary· NEUTRAL
- ·Aurobindo Pharma's growth is expected to be supported by the Pen-G project ramp-up.
- ·Integration of Lannett and new US product launches are anticipated to aid growth.
- ·Expansion in Europe and contributions from higher-margin businesses are also expected to drive growth.
VERIFIEDET Markets·101d★ ON YOUR LIST
Aurobindo Pharma among 9 mid-cap stocks to hit 52-week highs & rally up to 20% in a monthAI summary· POSITIVE
- ·Nine BSE Midcap stocks reached new 52-week highs on Monday.
- ·Aurobindo Pharma was among the mid-cap stocks that hit 52-week highs.
- ·Bank of Maharashtra, Thermax, Bharat Forge, Oracle Financial Services, and Laurus Labs were noted outperformers.
VERIFIEDET Stocks·101d★ ON YOUR LIST
Aurobindo Pharma among 9 mid-cap stocks to hit 52-week highs & rally up to 20% in a monthAI summary· POSITIVE
- ·Nine BSE Midcap stocks reached new 52-week highs on Monday.
- ·Aurobindo Pharma was among the mid-cap stocks that hit 52-week highs.
- ·Bank of Maharashtra, Thermax, Bharat Forge, Oracle Financial Services, and Laurus Labs were notable outperformers.
VERIFIEDEconomic Times News·102d★ ON YOUR LIST
Nifty has more room to run; stay selective: AnalystsAI summary· NEUTRAL
- ·Nifty is targeting the 24,300-25,000 zone amidst market volatility.
- ·Analysts suggest selective trading and strategies like a moderately bullish Call Spread.
- ·Recommended stocks include TVS Motor, Samvardhana Motherson International, Oberoi Realty, Aurobindo Pharma, Vijaya Diagnostic Centre, and Mahindra & Mahindra Financial Services.
REFERENCEGoogle News, India stocks·102d★ ON YOUR LIST
Stocks to Watch Today: Kotak Bank, Torrent Power, Persistent, Aurobindo Pharma, Dr Reddys Labs, KEC... - Moneycontrol.com